KiOmed Pharma 2025
KiOmed Pharma 2025
Type
funding
Amount
EUR 18M
Date
2025-01-01T00:00:00.000Z
TLDR
KiOmed Pharma raised EUR 18M in 2025 to advance its biopolymer-based medical solutions.
Overview
KiOmed Pharma raised EUR 18M in 2025. The company develops biopolymer-based products for orthopedic and ophthalmological applications, with a focus on hyaluronic acid derivatives.
See also
Team memberKiOmed Pharma
Categories:deals